The revenue stands at ₹1,353.73 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.92 per cent from ₹1,302.65 crore. This corresponds to a year-on-year *(YoY) growth of 14.08 per cent.
Operating Profit stands at ₹62.73 crore, reflecting a quarter-on-quarter *(QoQ) increase of 98.58 per cent from ₹31.59 crore. This corresponds to a year-on-year *(YoY) growth of 146.00 per cent.
PBDT stands at ₹123.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.56 per cent from ₹117.08 crore. This corresponds to a year-on-year *(YoY) growth of 14.28 per cent.
Profit Before Tax stands at ₹340.81 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.92 per cent from ₹331.13 crore. This corresponds to a year-on-year *(YoY) growth of 17.42 per cent.
Net Profit stands at ₹260.19 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.90 per cent from ₹255.34 crore. This represents a 20.19 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | -0.45% | 0.44% | 0.71% | 12.90% | -2.93% | 1.28% |
| Glaxosmi. Pharma | -3.32% | -0.78% | -6.22% | -13.96% | -26.73% | 12.05% |
| Ipca Labs. | -1.53% | -1.69% | 1.58% | 12.68% | -3.22% | 1.41% |
| Anthem Bioscienc | 0.70% | -0.93% | -6.84% | -16.87% | -19.45% | -16.58% |
| J B Chemicals & | -3.08% | -4.53% | 1.32% | 8.29% | 7.91% | 4.64% |
| Emcure Pharma | -2.38% | -1.77% | 6.33% | 12.77% | 8.21% | 24.17% |
| Gland Pharma | -1.55% | 0.20% | 1.73% | -12.28% | -16.52% | 16.75% |
Chairman (Non-Executive) : Mannalal B Agrawal
Vice Chairman : Madhusudan B Agrawal
Managing Director : Yogesh Agrawal
Vice President & Company Secretary : Gaurang Shah
Joint Managing Director : Rajesh M Agrawal
Independent Director : David Rasquinha
Independent Director : Medha Joshi
Independent Director : Simi Thapar
Independent Director : Rajesh Shashikant Dalal